Gastrointestinal oncology covers a diverse group of malignancies affecting the digestive system and associated organs. This session explores advances in the biology, diagnosis, treatment, and multidisciplinary management of colorectal, gastric, pancreatic, liver, esophageal, and other gastrointestinal cancers.
Abstract Scope and Participation
Abstracts may focus on colorectal, gastric, pancreatic, hepatobiliary, liver, esophageal, anal, and other gastrointestinal malignancies. Topics may include molecular profiling, surgery, systemic therapy, immunotherapy, targeted therapy, radiation, screening, and multidisciplinary management. Clinicians, researchers, surgeons, gastroenterologists, and allied specialists are invited.
Objective: To evaluate the efficacy and safety of high-intensity focused ultrasound ablation in the treatment of pancreatic cancer and to analyze relevant prognostic factors. Methods: A retrospective…
Objective :Endoscopic submucosal dissection (ESD) is widely used for early esophageal cancer,but the post-ESD stricture rate of patients with a post-ESD mucosal defect of ≥ 3/4 of the esophageal…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Gastrointestinal Cancer work, reviewed by the scientific committee.
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Gastrointestinal Cancer research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Gastrointestinal Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Gastrointestinal Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Cancer researchers and clinicians, educators and students with an interest in Gastrointestinal Cancer are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. CIOC 2027 is a hybrid conference — attend the Gastrointestinal Cancer track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
